Australia's largest stock trading and investment forum Australia's #1 stock forum

SHG

1.12%

9.0¢ singular health group ltd

General, page-16

First 16 Last

Share
Profile

Follow
Donnychong

1,201 Posts.

1368

18/06/24

18:33

Post #: 74375955
Share

Originally posted by Jimbill: ↑

Time will tell if it’s the right decision or not but I had a bit of nibble and topped up some more - my thinking is that Marin and Sons bought at 16c when the share price was 11c. They saw value there and no doubt won’t be happy to be 50% down on their money so will be working hard to get it back up.

1 decent contract and I think it bounces back up and whilst this drawdown is painful I think it’s a blessing in disguise as the company now understands how important it is to engage with the market and get the story understood.

Expand

Why not just buy on market tho? I get that the 15c & 16c placements allows SHG to access and use the funds, I just find it strange that there is absolutely no interest at all now at 8c. Surely both Marin & Sons + Sellars see value now ? Or am I missing something here.

Still very bullish about the future and direction of the company.

Last edited by Donnychong: 18/06/24

SHG Price at posting: 8.2¢ Sentiment: Hold Disclosure: Held
6 Upvote

3 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 54 more messages in this thread...

First 16 Last

Add SHG (ASX) to my watchlist

(20min delay)
Last 9.0¢		Change 0.001(1.12%)		Mkt cap ! $18.60M

Open	High	Low	Value	Volume
9.1¢	9.1¢	9.0¢	$30.35K	335.0K

Buyers (Bids)

No.	Vol.	Price($)
1	64648	9.0¢

Sellers (Offers)

Price($)	Vol.	No.
9.4¢	30000	1

View Market Depth

No.	Vol.	Price($)
1	64648	0.090
1	323	0.089
1	52393	0.088
2	61000	0.080
2	23030	0.076

Price($)	Vol.	No.
0.094	30000	1
0.095	36555	1
0.096	42630	1
0.097	37520	1
0.098	54020	2

Last trade - 13.05pm 04/10/2024 (20 minute delay)

SHG (ASX) Chart

General, page-16

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

General, page-16

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News